E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/3/2013 in the Prospect News PIPE Daily.

Merus Labs arranges C$4.58 million private placement of common stock

Proceeds to be used for debt repayment and general corporate purposes

By Devika Patel

Knoxville, Tenn., June 3 - Merus Labs International Inc. said it will conduct a C$4.58 million private placement of stock.

The company will sell 7,628,667 common shares at C$0.60 per share. The price per share is identical to the May 31 closing share price.

A 6% finder's fee will be paid to PowerOne Capital Markets Ltd.

Settlement is expected June 7.

Proceeds will be used for debt repayment and general corporate purposes.

The specialty pharmaceutical company is based in Toronto.

Issuer:Merus Labs International Inc.
Issue:Common shares
Amount:C$4,577,200
Shares:7,628,667
Price:C$0.60
Warrants:No
Pricing date:June 3
Settlement date:June 7
Stock symbol:Toronto: MSL
Stock price:C$0.60 at close May 31
Market capitalization:C$19.35 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.